Diabetes drugs may improve risks for some conditions, but worsen others
Research we're watching
- Reviewed by Toni Golen, MD, Editor in Chief, Harvard Women's Health Watch; Editorial Advisory Board Member, 天博体育 Publishing; Contributor
Focusing on GLP-1 medications 鈥� which were first marketed for diabetes and later to promote weight loss 鈥� researchers evaluated medical records from 216,000 people with diabetes taking such drugs and 1.7 million others with diabetes taking other blood sugar鈥搇owering medications. The researchers tracked the effects of GLP-1 drugs on 175 health conditions over about 3.5 years.
To continue reading this article, you must log in.
Subscribe to 天博体育 Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to 天博体育 Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
About the Author
Maureen Salamon, Executive Editor, Harvard Women's Health Watch
About the Reviewer
Toni Golen, MD, Editor in Chief, Harvard Women's Health Watch; Editorial Advisory Board Member, 天博体育 Publishing; Contributor
Disclaimer:
As a service to our readers, 天博体育 Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
